Reproductive and hormonal factors associated with mammographic breast density by age (United States)

Cancer Causes and Control

Volumn 11, Issue 10, 2000, Pages 955-963

  El Bastawissi, Amira Y ^a,b   White, Emily ^a,b   Mandelson, Margaret T ^c   Taplin, Stephen H ^c,d  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c CENTER FOR HEALTH STUDIES   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Age; Breast density; Hormone replacement therapy; Mammography; Reproduction

Indexed keywords

ESTROGEN;

ADULT; AGED; ARTICLE; BODY DENSITY; BREAST EPITHELIUM; DISEASE ASSOCIATION; FEMALE; HORMONE DETERMINATION; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NULLIPARA; PRIORITY JOURNAL; RISK FACTOR; UNITED STATES;

ADIPOSE TISSUE; ADULT; AGED; AGING; BODY MASS INDEX; BREAST; BREAST NEOPLASMS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MAMMOGRAPHY; MENOPAUSE; MIDDLE AGED; PARITY; PREGNANCY; REFERENCE VALUES; RISK FACTORS;

EID: 0034537665     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026514032085     Document Type: Article

References (56)

1. Mammographic features and breast cancer risk: Effects with time, age, and menopause status
2. The risk of breast cancer associated with mammographic parenchymal patterns: A meta-analysis of the published literature to examine the effect of method of classification
3. Radiographic patterns of the mammary parenchyma: Variation with age at examination and age at first birth
4. The relation of mammographic features of the breast to breast cancer risk factors
5. Factors associated with mammographic pattern
6. Plasma lipids in premenopausal women with mammographic dysplasia
7. Relationship of mammographic parenchymal patterns with breast cancer risk factors and risk of breast cancer in a prospective study
8. Mammographic densities and risk of breast cancer
9. Reproductive and menstrual factors in relation to mammographic parenchymal patterns among perimenopausal women
10. Breast mammographic pattern: A concatenation of confounding and breast cancer risk factors
11. A pilot study of mammographic density patterns among Japanese women
12. The relation between radiographic features and determinants of risk of breast cancer
13. Mammographic parenchymal patterns and risk factors for breast cancer
14. Selected prognostic variables for mammographic parenchymal patterns
15. Mammographic signs as risk factors for breast cancer
16. Breast cancer risk associated with reproductive factors and breast parenchymal patterns
17. A prospective study of mammographic parenchymal patterns and risk of breast cancer
18. Diet, mammographic features of breast tissue, and breast cancer risk
19. Variation in mammographic breast density by time in menstrual cycle among women aged 40-49 years
20. Mammographic parenchymal patterns: A marker of breast cancer risk
21. Effects on breast tissue of exogenous oestrogens and progestogens
22. Hormonal replacement therapy: Mammographic manifestations
23. Mammographic changes associated with postmenopausal hormone replacement therapy: A longitudinal study
24. The mammographic parenchymal patterns of women on hormonal replacement therapy
25. Pain and increased mammographic density in women receiving hormone replacement therapy: A prospective study
26. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern
27. Mammographic density in women on postmenopausal hormone replacement therapy
28. Effects of estrogen and estrogen-progestin on mammographic parenchymal density
29. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually
30. Variability and accuracy in mammographic interpretation using the American College of Radiology Breast Imaging Reporting and Data System
31. Breast parenchymal patterns and their changes with age
32. Association of abnormal nipple aspirate cytology and mammographic pattern and density
33. Analysis of parenchymal density on mammograms in 1353 women 25-79 years old
34. Risk factors for Wolfe's dysplasia of mammograms in postmenopausal Turkish women
35. Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence
36. Differentiation of the mammary gland and susceptibility to carcinogenesis
37. Influence of age and parity on the development of the human breast
38. Architectural pattern of the normal and cancerous breast under the influence of parity
39. Estrogen and sex hormone-binding globulin levels in nulliparous and parous women
40. Influence of pregnancy and lactation on serum and breast fluid estrogen levels: Implications for breast cancer risk
41. Breast cancer incidence in women with a history of progesterone deficiency
42. Breast physiology: Normal and abnormal development and function
43. Endogenous sex hormones, prolactin, and mammographic features of breast tissue in premenopausal women
44. Reproductive factors and breast cancer
45. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
46. Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: Associations and interactions in an international case-control study
47. Growth pattern and age at menarche of obese girls in a transitional society
48. Obesity and reproduction
49. Childhood obesity, adipose tissue distribution, and the pediatric practitioner
50. Western diet, early puberty, and breast cancer risk
51. Design of a study to improve accuracy in reading mammograms
52. Clinical trial of lowfat, high-carbohydrate diet in subjects with mammographic dysplasia: Report of early outcomes
53. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
54. The effect of raloxifene on risk of breast cancer in postmenopausal women: Results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation